Back

Inhibition of MMP prevents doxorubicin-induced cardiotoxicity by attenuating cardiac intracellular and extracellular matrix remodelling

Cardiovascular Research

10 July 2020
Organised by: Logo
Read full article
ESC Journals

Contributors

Inna Rabinovich-Nikitin
Inna Rabinovich-Nikitin

Author

Matthew Love
Matthew Love

Author

Lorrie A Kirshenbaum
Lorrie A Kirshenbaum

Author

Institute of Cardiovascular Sciences Winnipeg , Canada

You may be interested in
thumbnail
Congress Presentation
New target for chemotherapy-induced cardiac dysfunction
20 June 2025
thumbnail
Congress Presentation
Murine matrix metalloproteinase 13 and human matrix metalloproteinase 1 are involved in remodelling processes after myocardial infarction
12 April 2024
thumbnail
Congress Session
Role of multi-modality imaging for cardiomyopathy in children and young people
10 May 2023
thumbnail
Congress Presentation
Melt electrowritten 3D human cardiac engineered tissues reproduce the enhanced sensitivity of fibrotic patients to doxorubicin
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources